Concepedia

Ronald G. Browne

RG

19

Publications

1.5K

Citations

13

H-Index

1974

Active since

Affiliations

Pfizer (United States)(Current)

University of California San Diego

University of California, Irvine

The University of Texas Health Science Center at Houston

Texas Research Institute

Ronald G. Browne is an author at Pfizer (United States) specializing in medicine, neuropharmacology, and neuroscience.

Top concepts

Publications per year

1974–2000

19

Publications

19

4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants

Reinhard Sarges, Harry Howard, Ronald G. Browne et al. · Journal of Medicinal Chemistry · 1990 · 407 citations · Full text

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.

B. Kenneth Koe, Arthur D. Weissman, W. M. WELCH et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 257 citations · Full text

Analog Classroom Assessment of Adderall® in Children With ADHD

James M. Swanson, Sharon B. Wigal, Laurence L. Greenhill et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1998 · 218 citations

A Double-Blind, Placebo-Controlled Study of Adderall and Methylphenidate in the Treatment of Attention-Deficit/Hyperactivity Disorder

Steven R. Pliszka, Ronald G. Browne, Rene L. Olvera et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2000 · 132 citations

, , +11

Effects of antidepressants and anticholinergics in a mouse “behavioral despair” test

Ronald G. Browne · European Journal of Pharmacology · 1979 · 86 citations

, , +12

Rows per page

1–5 of 19